Recent News for FPRX - Five Prime Therapeutics, Inc.

Date Title
Oct 11 Insiders Roundup: Facebook, American Defense Systems
Oct 11 The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
Oct 11 South San Francisco biotech to cut another 70 jobs, may sublease space
Oct 10 Five Prime to restructure, axe 70 jobs
Oct 10 Five Prime Announces Restructuring
Oct 9 Microcaps mostly among midday movers
Oct 9 Five Prime Therapeutics leads healthcare gainers; Provention Bio tops the losers
Oct 9 Five Prime up 13% on insider buys
Oct 2 Looking for 1,600% Returns? Biotech Has No Shortage of Analyst Optimism
Oct 2 The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
Oct 1 The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
Sep 30 Five Prime Therapeutics Presents Updated Data From the Phase 1a/1b Trial of FPA150 at the European Society for Medical Oncology 2019 Congress
Sep 29 The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear
Sep 27 The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
Sep 26 The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
Sep 25 Stocks That Hit 52-Week Lows On Wednesday
Sep 20 Peninsula biotech CEO resigns in latest corner office switch
Sep 20 The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
Sep 19 New chief at Five Prime
Sep 19 Five Prime Therapeutics Announces Management Transition
Sep 19 What Kind Of Shareholder Owns Most Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Stock?
Aug 22 Five Prime Therapeutics to Present at Upcoming Healthcare Conference
Aug 10 Edited Transcript of FPRX earnings conference call or presentation 7-Aug-19 8:30pm GMT
Aug 10 Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q2 2019 Results - Earnings Call Transcript
Aug 8 Five Prime Therapeutics, Inc. 2019 Q2 - Results - Earnings Call Slides
Back to the Main FPRX Page...